by Ahmed S, Rutter P M
Ahmed S, Rutter P M. UK Community Pharmacists Experiences on Over-the-Counter Tamsulosin. SelfCare 2011;2(6):152-159
In the UK, government policy toward self-care now supports the management of some long-term conditions. In 2004, simvastatin was switched to P access for people who have a moderate risk of coronary heart disease. This deregulation met with opposition from pharmacists due to concern over patient management and the increased workload burden envisaged around training and record keeping. In 2010, tamsulosin was reclassified for the treatment of urinary symptoms of benign prostatic hyperplasia (BPH); the first medicine since simvastatin to be marketed for a non self-limiting condition. This study aimed to explore community pharmacist’s early experiences with the supply of non-prescription tamsulosin.
